Cambridge-founded automated cell analytics platform Sphere Fluidics has added $2m of funding, bringing its lifetime haul to $14.9m.

Sphere Fluidics, a UK-based automated cell analysis system spinout of University of Cambridge, closed a $2m round on Wednesday backed by investment firm Greenwood Way Capital. 24Haymarket also supplied capital, as did investment manager Oxford Technology and Innovations EIS Fund. Sphere Fluidics has devised an automated cell analytics platform branded Cyto-Mine that is able to…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.